Clinical Trial Update: Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on hypofractionated focal lesion ablative microboost for prostate cancer (adenocarcinoma) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Snippet

Sponsor: UMC Utrecht | Conditions: Prostate Cancer Adenocarcinoma | Phase 2 | Status: COMPLETED